Sanofi (SNY) Income from Discontinued Operations (2009 - 2026)

Sanofi has disclosed Income from Discontinued Operations across 14 years of filings, most recently posting $30.4 million for Q1 2026.

• In Q1 2026, Income from Discontinued Operations fell 83.37% year-over-year to $30.4 million; the TTM figure through Jun 2026 stood at $36.6 million (down 98.82% YoY), while the FY2025 annual figure was $3.3 billion, up 4929.62% from the prior year.
• Income from Discontinued Operations came in at $30.4 million for Q1 2026 at Sanofi, up from -$3.3 billion in the prior quarter.
• In the past five years, Income from Discontinued Operations ranged from a high of $3.3 billion in Q3 2025 to a low of -$3.3 billion in Q4 2025.
• Average Income from Discontinued Operations over 4 years is $288.4 million, with a median of $46.2 million recorded in 2024.
• The largest YoY upside for Income from Discontinued Operations was 7513.84% in 2025 against a maximum downside of 1655.15% in 2025.
• Over 4 years, Income from Discontinued Operations stood at -$472.3 million in 2023, then soared by 59.73% to -$190.2 million in 2024, then slumped by 1655.15% to -$3.3 billion in 2025, then jumped by 100.91% to $30.4 million in 2026.
• Per Business Quant data, the three most recent Income from Discontinued Operations figures were $30.4 million in Q1 2026, -$3.3 billion in Q4 2025, and $3.3 billion in Q3 2025.